PMID- 32131113 OWN - NLM STAT- MEDLINE DCOM- 20220131 LR - 20220131 IS - 1439-3646 (Electronic) IS - 0947-7349 (Linking) VI - 129 IP - 10 DP - 2021 Oct TI - Carotid Intima-Media Thickness is a Predictor of Subclinical Myocardial Damage in Men with Type 2 Diabetes Mellitus. PG - 750-756 LID - 10.1055/a-1107-2657 [doi] AB - BACKGROUND: Type 2 diabetes mellitus (T2DM) promotes the development of atherosclerosis and is a major risk factor for cardiovascular disease. High-sensitivity cardiac troponin I (hs-cTnI) assays fundamentally improved the diagnosis of myocardial injury and even enable the prediction of future cardiovascular events in the general population. However, data about the association of hs-cTnI with cardiovascular risk factors and carotid intima media thickness (cIMT) as a marker of atherosclerosis are limited, especially in patients with T2DM. METHODS: In this cross-sectional study we analyzed clinical and laboratory parameters of 234 patients (43% women) with T2DM and a median age of 65 years (interquartile range: 57-71). The median duration of diabetes mellitus was 10 years (6-17). Anthropometric data, blood pressure, glycemic parameters and lipid profiles were determined. Hs-cTnI plasma concentrations were measured on an ADVIA Centaur XPT immunoassay analyzer and cIMT was evaluated by high-resolution ultrasound. RESULTS: Hs-cTnI plasma concentrations were below the gender-specific 99(th) percentile in 93% of T2DM patients with a median concentration of 4.0 ng/l (interquartile range: 2.0-10.0). Hs-cTnI was significantly associated with gender, renal function and C-reactive protein in the entire study cohort. Gender-specific analyses revealed cIMT and renal function to be significantly associated with hs-cTnI in men. Contrary, only age was significantly associated with hs-cTnI in women. CONCLUSION: In a real-world clinical setting in patients with T2DM, cIMT is a predictor of subclinical myocardial damage in men, but not in women. CI - Georg Thieme Verlag KG Rudigerstrasse 14, 70469 Stuttgart, Germany. FAU - Horber, Sebastian AU - Horber S AD - Department for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tubingen, Germany. AD - Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tubingen, Germany. AD - German Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany. FAU - Lehn-Stefan, Angela AU - Lehn-Stefan A AD - Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tubingen, Germany. AD - German Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany. FAU - Hieronimus, Anja AU - Hieronimus A AD - Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tubingen, Germany. AD - German Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany. AD - Department of Internal Medicine IV, Division of Endocrinology and Diabetology, Nephrology University Hospital of Tubingen, Germany. FAU - Hudak, Sarah AU - Hudak S AD - Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tubingen, Germany. AD - German Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany. AD - Department of Internal Medicine IV, Division of Endocrinology and Diabetology, Nephrology University Hospital of Tubingen, Germany. FAU - Fritsche, Louise AU - Fritsche L AD - Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tubingen, Germany. AD - German Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany. AD - Department of Internal Medicine IV, Division of Endocrinology and Diabetology, Nephrology University Hospital of Tubingen, Germany. FAU - Fritsche, Andreas AU - Fritsche A AUID- ORCID: 0000-0002-4987-1961 AD - Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tubingen, Germany. AD - German Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany. AD - Department of Internal Medicine IV, Division of Endocrinology and Diabetology, Nephrology University Hospital of Tubingen, Germany. FAU - Heni, Martin AU - Heni M AD - Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tubingen, Germany. AD - German Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany. AD - Department of Internal Medicine IV, Division of Endocrinology and Diabetology, Nephrology University Hospital of Tubingen, Germany. FAU - Haring, Hans-Ulrich AU - Haring HU AD - Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tubingen, Germany. AD - German Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany. AD - Department of Internal Medicine IV, Division of Endocrinology and Diabetology, Nephrology University Hospital of Tubingen, Germany. FAU - Peter, Andreas AU - Peter A AD - Department for Diagnostic Laboratory Medicine, Institute for Clinical Chemistry and Pathobiochemistry, University Hospital Tubingen, Germany. AD - Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tubingen, Germany. AD - German Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany. FAU - Randrianarisoa, Elko AU - Randrianarisoa E AD - Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tubingen, Germany. AD - German Center for Diabetes Research (DZD), Munchen-Neuherberg, Germany. LA - eng PT - Journal Article DEP - 20200304 PL - Germany TA - Exp Clin Endocrinol Diabetes JT - Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association JID - 9505926 RN - 0 (Troponin I) SB - IM MH - Adult MH - Aged MH - *Carotid Intima-Media Thickness MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/*complications MH - Diabetic Cardiomyopathies/blood/*diagnosis/etiology MH - Female MH - Humans MH - Male MH - Middle Aged MH - Prognosis MH - Sex Factors MH - Troponin I/*blood COIS- The authors declare that they have no conflict of interest. EDAT- 2020/03/05 06:00 MHDA- 2022/02/01 06:00 CRDT- 2020/03/05 06:00 PHST- 2020/03/05 06:00 [pubmed] PHST- 2022/02/01 06:00 [medline] PHST- 2020/03/05 06:00 [entrez] AID - 10.1055/a-1107-2657 [doi] PST - ppublish SO - Exp Clin Endocrinol Diabetes. 2021 Oct;129(10):750-756. doi: 10.1055/a-1107-2657. Epub 2020 Mar 4.